This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at the ...
Cardiovascular Surgery
This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.
December 11, 2018 — The scientific journal Nature recently published an article from Munich University Hospital which ...
November 2, 2018 — Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are ...
October 25, 2018 — On Oct. 18, 2018, LivaNova issued a Medical Device Correction letter to inform customers of actions ...
![A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.](/sites/default/files/styles/content_feed_large/public/field/image/LVAD_Left-ventricular-assist_Abbott-HeartMate3_Heart-Failure_Patient_staff_photo_ACC18.jpg?itok=Rn4Ed9VU)
October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S ...
![Two of the top videos in September both had to do with interventional cardiology hemodynamic support support protocols. The top piece of content in September is an interview on the protocols used to determine what device technology to use at Henry Ford Hospital in Detroit. Number 13 on the list is another video on late-breaking data presented TCT 2018 from the National Cardiogenic Shock Initiative (NCSI) where mortality was improved by 50 percent over the current standard of care. Pictured here are Abiomed](/sites/default/files/styles/content_feed_large/public/field/image/Abiomed_Imprella_percutaneous_heart-pump_VAD_TCT17_Staff_photo-1.jpg?itok=aalfSfQy)
October 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
September 25, 2018 — Five-month-old Jack Palmer is home with his family in Kansas City after undergoing an extremely ...
September 6, 2018 — While it is firmly established that the use of one internal thoracic artery can improve life ...
July 26, 2018 — The number of patients undergoing mitral valve operations are at an all-time high, and new research ...
May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a ...
![The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.](/sites/default/files/styles/content_feed_large/public/field/image/X0000_Portola_Andexxa-vial-Factopr_xa_reversal-agent.jpg?itok=Ra134DaN)
May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first ...
April 30, 2018 – Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was ...
March 30, 2018 — LivaNova PLC announced the first patient enrollment in the Perceval Valve Clinical study for Chinese ...
February 27, 2018 – A new study published in the Journal of the American College of Cardiology confirms non-invasive car ...
February 22, 2018 — AtriCure Inc. announced that it has launched the AtriClip FLEX•V Left Atrial Appendage (LAA) ...